ºù«Ӱҵ

Journal articles

• Cai H, Liu D, Xue W-W, Ma L, Xie H-T & Ning K (2024) . Translational Neuroscience, 15(1), 20220359.
• Ning K, Sandoval-Castellanos A, Bhargava A, Zhao M & Xu J (2023) . Neural Regeneration Research, 18(7), 1411-1411.
• Wu B, Feng J, Guo J, Wang J, Xiu G, Xu J, Ning K, Ling B, Fu Q & Xu J (2022) . Stem Cell Research & Therapy, 13(1).
• Bhargava A, Sandoval Castellanos AM, Shah S & Ning K (2022) . Interface Focus, 12(5).
• Karyka E, Berrueta Ramirez N, Webster CP, Marchi PM, Graves EJ, Godena VK, Marrone L, Bhargava A, Ray S, Ning K , Crane H et al (2022) . Life Science Alliance, 5(8), e202101145-e202101145.
• Wang J, Hao R, Jiang T, Guo X, Zhou F, Cao L, Gao F, Wang G, Wang J, Ning K , Zhong C et al (2022) . Cell & Bioscience, 12(1).
• Ren J, Wang X, Dong C, Wang G, Zhang W, Cai C, Qian M, Yang D, Ling B, Ning K , Mao Z et al (2022) . Stem Cells.
• Zhang S, Cooper-Knock J, Weimer AK, Shi M, Moll T, Marshall JNG, Harvey C, Nezhad HG, Franklin J, Souza CDS , Ning K et al (2022) . Neuron.
• Castelli LM, Cutillo L, Souza CDS, Sanchez-Martinez A, Granata I, Lin Y-H, Myszczynska MA, Heath PR, Livesey MR, Ning K , Azzouz M et al (2021) . Molecular Neurodegeneration, 16(1).
• Wind M, Gogolou A, Manipur I, Granata I, Butler L, Andrews PW, Barbaric I, Ning K, Guarracino MR, Placzek M & Tsakiridis A (2021) . Development, 148(6).
• de Matos AM, Blázquez-Sánchez MT, Bento-Oliveira A, de Almeida R, Nunes RS, LOpes P, Machuqueiro M, Cristovão J, Gomes CM, Souza CS , El Idrissi IG et al (2020) . Journal of Medicinal Chemistry.
• Zhou X, Ning K, Ling B, Chen X, Cheng H, Lu B, Gao Z & Xu J (2019) . Stem Cells and Development, 28(21), 1463-1472.
• Gao S, Guo X, Zhao S, Jin Y, Zhou F, Yuan P, Cao L, Wang J, Qiu Y, Sun C , Kang Z et al (2019) . Cell Death & Disease, 10(8).
• Matos AM, Man T, Idrissi I, Souza CC, Mead E, Dunbar C, Wolak J, Oliveira MC, Evans D, Grayson J , Partridge B et al (2019) . Pure and Applied Chemistry, 91(7).
• Zhu L, Sun C, Ren J, Wang G, Ma R, Sun L, Yang D, Gao S, Ning K, Wang Z , Chen X et al (2019) . Cell Death & Disease, 10(2).
• Sun C, Zhu L, Ma R, Ren J, Wang J, Gao S, Yang D, Ning K, Ling B, Lu B , Chen X et al (2019) . Cell Death & Disease, 10(2).
• Alrafiah A, Karyka E, Coldicott I, Iremonger K, Lewis K, Ning K & Azzouz M (2018) . Molecular Therapy - Methods and Clinical Development, 9, 81-89.
• Castelli LM, Lin YH, Ferraiuolo L, Sanchez-Martinez A, Ning KE, Azzouz M, Whitworth A, Shaw PJ & Hautbergue GM (2018) . Therapeutic Targets for Neurological Diseases, 4.
• Jin Y, Wang J, Li H, Gao S, Shi R, Yang D, Wang X, Wang X, Zhu L, Wang X , Chen C et al (2018) . EBioMedicine, 34, 231-242.
• Ciervo Y, Ning K, Jun X, Shaw PJ & Mead RJ (2017) . Molecular Neurodegeneration, 12, 85-85.
• Dong C-M, Wang X-L, Wang G-M, Zhang W-J, Zhu L, Gao S, Yang D-J, Qin Y, Liang Q-J, Chen Y-L , Deng H-T et al (2017) . Cell Death and Disease, 8(9).
• Bowerman M, Becker CG, Yáñez-Muñoz RJ, Ning K, Wood MJA, Gillingwater TH, Talbot K & UK SMA Research Consortium (2017) . Dis Model Mech, 10(8), 943-954.
• Hautbergue GM, Castelli LM, Ferraiuolo L, Sanchez-Martinez A, Cooper-Knock J, Higginbottom A, Lin YH, Bauer CS, Dodd JE, myszczynska MA , Alam SM et al (2017) . Nature Communications, 8.
• Godena VK & Ning K (2017) . Signal Transduction and Targeted Therapy, 2(1).
• Wang X, Dong C, Sun L, Zhu L, Sun C, Ma R, Ning K, Lu B, Zhang J & Xu J (2016) . Scientific Reports, 6.
• Seytanoglu A, Alsomali NI, Valori CF, McGown A, Kim HR, Ning K, Ramesh T, Sharrack B, Wood JD & Azzouz M (2016) . Neuroscience, 322, 287-297.
• Little D, Valori CF, Mutsaers CA, Bennett EJ, Wyles M, Sharrack B, Shaw PJ, Gillingwater TH, Azzouz M & Ning K (2015) . Molecular Therapy, 23(2), 270-277.
• Dong C-M, Wang X-L, Wang G-M, Zhang W-J, Zhu L, Gao S, Yang D-J, Qin Y, Liang Q-J, Chen Y-L , Deng H-T et al (2014) . Cell Death Dis, 5, e1116.
• Yang D-J, Wang X-L, Ismail A, Ashman CJ, Valori CF, Wang G, Gao S, Higginbottom A, Ince PG, Azzouz M , Xu J et al (2014) . Cell Death Dis, 5, e1096.
• Ning K (2013) Differentiation of Human-Adipose Derived Stem Cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds.. Tissue Eng Part A..
• Nanou A, Higginbottom A, Valori CF, Wyles M, Ning K, Shaw P & Azzouz M (2013) . Mol Ther, 21(8), 1486-1496.
• Brockington A, Ning K, Heath PR, Wood E, Kirby J, Fusi N, Lawrence N, Wharton SB, Ince PG & Shaw PJ (2013) . Acta Neuropathol, 125(1), 95-109.
• Ismail A, Ning K, Al-Hayani A, Sharrack B & Azzouz M (2012) . TRANSLATIONAL NEUROSCIENCE, 3(2), 132-142.
• Ismail A, Ning K, Sharrack B & Azzouz M (2011) Impact of PTEN modulation on motor neuron survival in experimental models of motor neuron disease. HUMAN GENE THERAPY, 22(10), A62-A62.
• Little D, Ning K, Nanou A, Wang LG, Canton I, Battaglia G & Azzouz M (2011) Polymersome mediated gene therapy for spinal muscular atrophy. HUMAN GENE THERAPY, 22(10), A83-A84.
• Ning K, Drepper C, Valori CF, Wyles M, Ismail A, Higginbottom A, Herrmann T, Shaw PJ, Sendtner M & Azzouz M (2011) PTEN signalling in motor neuron disease (ALS & SMA). HUMAN GENE THERAPY, 22(10), A64-A64.
• Nanou A, Higginbottom A, Wyles M, Ning K, Shaw P & Azzouz M (2011) Gene therapy approaches to evaluate neuroprotection in experimental models of Amyotrophic Lateral Sclerosis. HUMAN GENE THERAPY, 22(10), A64-A64.
• Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo S-W, Valori CF, Cox L, Sharrack B, Wharton SB , Ince PG et al (2011) . Brain, 134(Pt 2), 506-517.
• Willmann R, Dubach J & Chen K (2011) . Neuromuscular Disorders, 21(1), 74-77.
• Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ & Azzouz M (2010) . Sci Transl Med, 2(35), 35ra42.
• Ning K, Miller LC, Laidlaw HA, Watterson KR, Gallagher J, Sutherland C & Ashford MLJ (2009) . J Biol Chem, 284(14), 9331-9340.
• Valori CF, Ning K, Wyles M & Azzouz M (2008) . Curr Gene Ther, 8(6), 406-418.
• Li L, El-Hayek YH, Liu B, Chen Y, Gomez E, Wu X, Ning K, Li L, Chang N, Zhang L , Wang Z et al (2008) . Stem Cells, 26(8), 2193-2200.
• Ning K, Miller LC, Laidlaw HA, Burgess LA, Perera NM, Downes CP, Leslie NR & Ashford MLJ (2006) . EMBO J, 25(11), 2377-2387.
• Liu B, Liao M, Mielke JG, Ning K, Chen Y, Li L, El-Hayek YH, Gomez E, Zukin RS, Fehlings MG & Wan Q (2006) . J Neurosci, 26(20), 5309-5319.
• Mirshamsi S, Laidlaw HA, Ning K, Anderson E, Burgess LA, Gray A, Sutherland C & Ashford MLJ (2004) . BMC Neurosci, 5, 54.
• Ning K, Li L, Liao M, Liu B, Mielke JG, Chen Y, Duan Y, El-Hayek YH & Wan Q (2004) . Nat Neurosci, 7(5), 489-490.
• Ning K, Pei L, Liao M, Liu B, Zhang Y, Jiang W, Mielke JG, Li L, Chen Y, El-Hayek YH , Fehlings MG et al (2004) . J Neurosci, 24(16), 4052-4060.
• Peters PJ, Ning K, Palacios F, Boshans RL, Kazantsev A, Thompson LM, Woodman B, Bates GP & D'Souza-Schorey C (2002) . Nat Cell Biol, 4(3), 240-245.
• Muchowski PJ, Ning K, D'Souza-Schorey C & Fields S (2002) . Proc Natl Acad Sci U S A, 99(2), 727-732.
• Ning K, Wang ZG, Chen CC, Li JM & Zhu PF (1999) Effects of excitatory amino acids and nimodipine on calcium currents in cultured rat cortical neurons.. Zhongguo Yao Li Xue Bao, 20(4), 329-332.
• Ning K () . European Journal of Molecular & Clinical Medicine, 2(2), 68-68.
• Grayson JD, Baumgartner MP, Santos Souza CD, Dawes SJ, El Idrissi IG, Louth JC, Stimpson S, Mead E, Dunbar C, Wolak J , Sharman G et al () . Chemical Science.

Conference proceedings papers

• Bhargava A, Ramesh T, Shaw PJ & Ning K (2022) Identification of Arfaptin-2 as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis (ALS) Using iPSC-Derived Motor Neurons and Zebrafish as Models of ALS. MOLECULAR THERAPY, Vol. 30(4) (pp 298-299)
• Bradley S, Godena VK, Azzouz M & Ning K (2019) Spinal muscular atrophy: The combined effect of coSMN expression and PTEN depletion in vitro. HUMAN GENE THERAPY, Vol. 30(8) (pp A20-A20)
• Ning K, Godena VK, Souza CDS, Arya S, Gillingwater TH, Talbot K & Azzouz M (2019) PTEN as therapeutic target for spinal muscular atrophy (SMA). HUMAN GENE THERAPY, Vol. 30(8) (pp A26-A26)
• Ren J, Ning K & Xu J (2019) Establishing cerebral organoids as models for amyotrophic lateral sclerosis (ALS). HUMAN GENE THERAPY, Vol. 30(8) (pp A28-A28)
• Mohammedeid A, Bhargava A, Godena VK, Kong S, Tennore R, Grierson AJ, Xu J, Shaw PJ, Azzouz M & Ning K (2019) Arfaptin-2 as a therapeutic target for amyotrophic lateral sclerosis (ALS). HUMAN GENE THERAPY, Vol. 30(8) (pp A19-A20)
• Ciervo Y, Coldicott I, Myszczynska M, Stopford M, Allen C, Grierson A, Xu J, Ferraiuolo L, Ning K, Shaw PJ & Mead RJ (2019) Adipose derived stem cells for cell therapy of motor neuron disease (MND). HUMAN GENE THERAPY, Vol. 30(8) (pp A16-A16)
• Godena V, Arya S, Gillingwater TH, Hammond S, Bowerman M, Wood M, Talbot K, Azzouz M & Ning K (2019) A stem cell model of spinal muscular atrophy (SMA): Assessing combinatorial drug therapies. HUMAN GENE THERAPY, Vol. 30(8) (pp A12-A13)
• Alsomali N, Seytanoglu A, Valori C, Kim HR, Ning K, Ramesh T, Sharrack B, Wood JD & Azzouz M (2014) Deficiency in Gle1, an mRNA export mediator, inhibits Schwann cell development in the zebrafish embryo. FEBS JOURNAL, Vol. 281 (pp 771-771)
• Mohammedeid A, Ning K, Kong SC, Azzouz M & Grierson A (2014) Regulation of protein aggregation by Arfaptin2 in amyotrophic lateral sclerosis. HUMAN GENE THERAPY, Vol. 25(5) (pp A14-A14)
• Little D, Valori C, Wyles M, Shaw P, Azzouz M & Ning K (2013) Systemic delivery of scAAV9 expressing PTEN siRNA prolongs survival in a model of spinal muscular atrophy. HUMAN GENE THERAPY, Vol. 24(5) (pp A27-A27)
• Binny C, Karyka E, Ning K, Bennett E, Ince P, Shaw P & Azzouz M (2013) Efficient scAAV9-mediated delivery of SMN to motor neurons in neonatal and juvenile mice. HUMAN GENE THERAPY, Vol. 24(5) (pp A38-A38)
• Brockington A, Ning K, Heath P, Wood E, Malik K, Fusi N, Wharton S, Ince PG & Shaw PJ (2012) . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 83(3)
• Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ & Azzouz M (2010) Systemic delivery of scAAV9 expressing SMN prolongs survival in a mouse model of SMA. HUMAN GENE THERAPY, Vol. 21(10) (pp 1424-1425)
• Azzouz M, Valori C, Ning K & Wyles M (2010) Current Advances in Gene Therapy for Spinal Muscular Atrophy. HUMAN GENE THERAPY, Vol. 21(10) (pp 1388-1389)
• Valori C, Ning K, Wyles M & Azzouz M (2010) Complete Rescue of SMA Mouse Model by Systemic Delivery of scAAV9 Mediating SMN Replacement. NEUROLOGY, Vol. 74(9) (pp A287-A287)
• Nanou A, Higginbottom A, Valori C, Wyles M, Ning K, Shaw P & Azzouz M (2010) Oxidative Stress as Target for Neuroprotection in Experimental Models of Amyotrophic Lateral Sclerosis (ALS). NEUROLOGY, Vol. 74(9) (pp A436-A436)
• Ning K, Drepper C, Ismail A, Valori CF, Wyles M, Higginbottom A, Herrmann T, Shaw P, Sharrack B, Sendtner M & Azzouz M (2010) PTEN Depletion Rescues the beta-Actin Deficit in Axonal Growth Cones in Motoneurons from a Mouse Model of Spinal Muscular Atrophy. NEUROLOGY, Vol. 74(9) (pp A489-A489)
• Goodhead LH, Ning K, Azzouz M, Kingsman SM, Mitrophanous KA & Ralph GS (2008) Optimizing EIAV vectors and delivery routes for ALS gene therapy. HUMAN GENE THERAPY, Vol. 19(4) (pp 405-405)
• Ning K & Wan Q (2007) Regulation of NMDA receptors by the phosphatase PTEN. JOURNAL OF NEUROCHEMISTRY, Vol. 102 (pp 147-147)
• El-Hayek YH, Gomez G, Ning K, Liao MX & Wan Q (2006) . INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, Vol. 24(8) (pp 590-591)
• Ning K, Pei L, Liao M, Liu B, Zhang Y, Jiang W, Mielke JG, Li L, Chen YH, El-Hayek YH , Fehlings MG et al (2004) Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. JOURNAL OF NEUROCHEMISTRY, Vol. 90 (pp 146-146)

Preprints

• Wang J, Hao R, Guo X, Zhou F, Cao L, Gao F, Wang G, Ning K, Chen X, Huang Y , Xu J et al () , Research Square Platform LLC.
• Castelli LM, Cutillo L, Souza CDS, Sanchez-Martinez A, Granata I, Myszczynska MA, Heath PR, Livesey MR, Ning K, Azzouz M , Shaw PJ et al () , Cold Spring Harbor Laboratory.
• Wind M, Gogolou A, Manipur I, Granata I, Butler L, Andrews PW, Barbaric I, Ning K, Guarracino MR, Placzek M & Tsakiridis A () .